WEBULL
News
SXTPW
0.0380
-5.00%
-0.0020
Weekly Report: what happened at SXTPW last week (0302-0306)?
Weekly Report · 15h ago
Weekly Report: what happened at SXTPW last week (0223-0227)?
Weekly Report · 03/02 09:39
Weekly Report: what happened at SXTPW last week (0216-0220)?
Weekly Report · 02/23 09:38
Weekly Report: what happened at SXTPW last week (0209-0213)?
Weekly Report · 02/16 09:38
60 DEGREES PHARMACEUTICALS INC - COMPANY REGAINED COMPLIANCE WITH NASDAQ MINIMUM BID PRICE - SEC FILING
Reuters · 02/12 14:00
Weekly Report: what happened at SXTPW last week (0202-0206)?
Weekly Report · 02/09 09:40
60 Degrees Pharmaceuticals Partners with GoodRx to Offer Savings on Malaria Drug ARAKODA
Reuters · 02/02 13:02
60 DEGREES PHARMACEUTICALS EXPANDS ACCESS TO ARAKODA® WITH GOODRX PARTNERSHIP
Reuters · 02/02 13:01
Weekly Report: what happened at SXTPW last week (0126-0130)?
Weekly Report · 02/02 09:39
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
Barchart · 02/02 07:01
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
Barchart · 01/28 07:01
Weekly Report: what happened at SXTPW last week (0119-0123)?
Weekly Report · 01/26 09:39
Nasdaq Moves to Delist 60 Degrees Pharmaceuticals Over Listing Rule Violation
Reuters · 01/26 07:27
60 Degrees Pharmaceuticals Partners with Runway Health to Expand Access to Malaria Prevention
Reuters · 01/22 13:02
60 DEGREES PHARMACEUTICALS ANNOUNCES PARTNERSHIP WITH RUNWAY HEALTH TO PROVIDE INTERNATIONAL TRAVELERS DIRECT ACCESS TO ARAKODA® FOR MALARIA PREVENTION
Reuters · 01/22 13:01
60 DEGREES PHARMACEUTICALS INC - PARTNERSHIP WITH RUNWAY HEALTH COMMENCES APRIL 2, 2026
Reuters · 01/22 13:01
60 Degrees Pharmaceuticals Announces 1-for-4 Reverse Stock Split
Reuters · 01/21 21:07
Weekly Report: what happened at SXTPW last week (0112-0116)?
Weekly Report · 01/19 09:43
NASDAQ TRADE HALT CONTINUES <SXTP.O> HALT NEWS PENDING AT 03:28 AM
Reuters · 01/17 08:28
60 Degrees Pharmaceuticals Announces 1-for-4 Reverse Stock Split
Reuters · 01/15 13:02
More
Webull provides a variety of real-time SXTPW stock news. You can receive the latest news about 60 Degrees Pharm through multiple platforms. This information may help you make smarter investment decisions.
About SXTPW
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.